The CEO of Pyxis Oncology is Lara S. Sullivan, M.D.
Leadership at Pyxis Oncology
Pyxis Oncology, a company dedicated to advancing oncology treatments, is led by Lara S. Sullivan, M.D. She serves as both the President and Chief Executive Officer, a role in which she guides the company's strategic vision and operational initiatives.
Dr. Sullivan's leadership is instrumental in Pyxis Oncology's endeavors within the biotechnology and pharmaceutical sectors, including significant corporate activities like the acquisition of Apexigen. Her background as a medical doctor combined with her executive experience provides a robust foundation for steering the company's focus on innovative cancer therapies.
Here's a clear overview of the top leadership position:
| Role | Name |
|---|---|
| President & CEO | Lara S. Sullivan, M.D. |
For further details on Pyxis Oncology's corporate news and leadership statements, their official news releases, such as the one detailing the acquisition of Apexigen, are available on their investor relations website: Pyxis Oncology News Releases.
